ODM-204
- Generic Name
- ODM-204
Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2019-12-19
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 23
- Registration Number
- NCT02344017
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
🇱🇻P. Stradins Clinical University Hospital, Riga, Latvia
🇫🇷Institut Gustave Roussy, Villejuif, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath